Gaitianli Pharmaceutical Co, based in Qidong, Nantong, Jiangsu province, delivered boxes of huai er ke li worth 200,000 yuan ($28,650) to Huangguang Central Hospital in Hubei province on Feb 15.

Huai er ke li is a kind of Chinese medicine that treats lack of vital energy and blood stasis. It is expected to be used in the clinical treatment of novel coronavirus disease (COVID-19).

The Qidong-based company, established in 1995, focuses on developing, producing and selling Chinese patent drugs. It engages in the treatment of tumors and immune diseases and has made great achievements.

As a national class I anti-cancer drug developed by the company, the huai er ke li has won several patents for invention and the National Prize for Progress in Science and Technology.

Gaitianli Pharmaceutical, a Qidong-based company, delivers boxes of huai er ke li to Huangguang Central Hospital in Hubei province on Feb 15. [Photo/ntfabu.com]